The global pharmaceuticals industry has been on the front line of managing and treating the Covid-19 pandemic, and as a result has faced many challenges in reshaping how medicines are tested, manufactured, and brought to market for healthcare. Overcoming these challenges has enabled organizations to unlock a level of agility and flexibility that had been previously untapped, and in doing so has introduced more effective operating models - many of which encompass increased or more sophisticated uses of technology.
The sector faces many of the same challenges as it did before the pandemic arrived, including some of the tightest regulations of any industry, new competition, and the end of patents for some blockbuster medications.
This paper looks to understand how pharmaceuticals organizations are tackling these challenges with intelligent automation; the key benefits and challenges associated with this, and their key drivers for greater transformation.
Download this report to learn how healthcare automation can transform pharmaceuticals
If your network blocks YouTube, you may not be able to view the video on this page. In this case, please use another device. Pressing play on the video will set third-party YouTube cookies. Please read our Cookies Policy for more information.